Search details
1.
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.
Oncologist
; 23(7): 782-790, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29572245
2.
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Invest New Drugs
; 32(4): 700-9, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24711126
3.
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
Oncologist
; 18(3): 271-2, 2013.
Article
in English
| MEDLINE | ID: mdl-23485624
4.
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).
Melanoma Res
; 31(2): 162-172, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33661190
5.
Phase I study of pazopanib plus TH-302 in advanced solid tumors.
Cancer Chemother Pharmacol
; 79(3): 611-619, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28238078
Results
1 -
5
de 5
1
Next >
>>